|Security||LJPC / La Jolla Pharmaceutical Co. (503459604)|
|Latest Market Date||2018-03-19|
LJPC / La Jolla Pharmaceutical Co. short volume is shown in the following chart. Short Volume is a data set that can be used to understand investor sentiment. When an investor makes a short sale, they do so with the belief that a security will decline in price. If the short sale volume increases as a percentage of the total volume, then that suggests a bearish (negative) sentiment by the market. If short sale volume decreases as a percentage of total volume, then that suggests a bullish (positive) sentiment.
- Short Volume
- Total number of short shares traded on the major US markets each day
- Short Percent
- Total number of short shares traded divided by the total shares traded each day
- Short Interest
- Total number of open short positions of a security, divided by the total float (not shown)
- Short Squeeze
- When a company with a high degree of short interest increases in price, which forces short sellers to "cover" their short interest buy buying actual shares, which in turn drives the price up even further.
Note that Short Percent on this page is not the same as Short Interest. Short Interest is a measure of the number of open short positions of a security, divided by the total float. Short Percent is the daily short volume divided by the total volume. Short Interest is not available for this security at this time.
|Market Date||Total Volume||Short Volume||Short Percent|
Peers - Biological Products, Except Diagnostic Substances (Biotech) (2836)
HEB / Hemispherx BioPharma, Inc.
AST / Asterias Biotherapeutics, Inc.
BIEI / Premier Biomedical Inc
CLDN / Celladon Corporation
Related News Stories
Today we will discuss Abeona Therapeutics (ABEO) after the company announced that it has nabbed a Rare Pediatric Disease designation from the FDA for ABO-202 for the treatment of CLN1 disease, which is a rare inherited disorder of the nervous system. (159-2)
For investors who have watched the staggering moves in bitcoin and somehow feel that they missed the bus, they were reminded last week when the cryptocurrency dropped back almost 35% just how insanely volatile the trade can be. While it may yet to prove to be the new standard for payment in the future, that sure won’t be the case anytime soon. (252-14)
How to find special situation and event-driven opportunities, merger arb and distressed investing are topics discussed and Value Detective shares a bullish thesis on PICO Holdings and Cision. (24-1)
The market potential for La Jolla's primary asset, a treatment for hypo-tension in Septic Shock patients, is severely overestimated in my opinion. (250-8)
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (418-2)